{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:04:57Z","timestamp":1789790697456,"version":"4.0.1"},"reference-count":37,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Laryngoscope"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Central\/peripheral vagal hypersensitivity underpins laryngeal sensory dysfunction (LSD). Botulinum toxin type A (BoNT\u2010A) injection has emerged as a targeted treatment for modulating laryngeal sensory pathways. This study aimed to evaluate short\u2010term outcomes and predictors of response following supraglottic BoNT\u2010A injection in patients with refractory LSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study of patients undergoing supraglottic BoNT\u2010A injection treatment between 2019 and 2025 for LSD symptoms refractory to medical\/behavioral therapy. Outcome measures included the Newcastle Laryngeal Hypersensitivity Questionnaire (LHQ), Reflux Symptom Index (RSI), Cough Severity Index (CSI), and Voice Handicap Index\u201010 (VHI\u201010). Pre\u2010 and post\u2010treatment scores were compared using paired statistical tests and effect size estimation. Treatment characteristics and follow\u2010up duration were reported, along with attainment of minimal clinically important difference (MCID) and predictors of response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty consecutive patients (mean age 58.3\u2009years; 48 female) showed significant improvement across hypersensitivity domains: LHQ +3.1 (95% CI: 2.4\u20133.8,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), RSI \u22127.9 points (95% CI: \u22129.7 to \u22125.8,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), CSI \u22125.7 points (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). VHI\u201010 was unchanged (\u22121.3,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.20). MCID thresholds were achieved in 64% for LHQ and 56% for RSI. Overall, 71% of patients reported phenotypic and clinically relevant improvement. Patients with a positive short\u2010term superior laryngeal nerve (SLN) block were more likely to respond to supraglottic BoNT. No serious complications occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Supraglottic BoNT\u2010A injection is a safe, effective treatment for laryngeal sensory dysfunction targeting the sensory field of the SLN to provide clinically meaningful reductions in throat irritation without compromising voice function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>4.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/lary.70841","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:45:47Z","timestamp":1789789547000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3839-1353","authenticated-orcid":false,"given":"Daniel","family":"Novakovic","sequence":"first","affiliation":[{"name":"Sydney Voice Lab, Faculty of Medicine and Health University of Sydney  Camperdown New South Wales Australia"},{"name":"Sydney Voice and Swallowing  St Leonards New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Sandham","sequence":"additional","affiliation":[{"name":"Sydney Voice Lab, Faculty of Medicine and Health University of Sydney  Camperdown New South Wales Australia"},{"name":"Sydney Voice and Swallowing  St Leonards New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Emslie","family":"Stewart","sequence":"additional","affiliation":[{"name":"Sydney Voice and Swallowing  St Leonards New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Jordan","family":"Johnston","sequence":"additional","affiliation":[{"name":"Sydney Voice Lab, Faculty of Medicine and Health University of Sydney  Camperdown New South Wales Australia"},{"name":"Department of Surgery University of Auckland  Auckland Auckland Region New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0892-1997(99)80049-6","article-title":"The Irritable Larynx Syndrome","volume":"13","author":"Morrison M.","year":"1999","journal-title":"Journal of Voice"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000348940511400401","article-title":"Chronic Cough as a Sign of Laryngeal Sensory Neuropathy: Diagnosis and Treatment","volume":"114","author":"Lee B.","year":"2005","journal-title":"Annals of Otology, Rhinology, and Laryngology"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jvoice.2010.07.009","article-title":"Chronic Refractory Cough as a Sensory Neuropathy: Evidence From a Reinterpretation of Cough Triggers","volume":"25","author":"Vertigan A. E.","year":"2011","journal-title":"Journal of Voice"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2309906","article-title":"Unexplained or Refractory Chronic Cough in Adults","volume":"392","author":"Irwin R. S.","year":"2025","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_10_6_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h5590","article-title":"Management of Chronic Refractory Cough","volume":"351","author":"Gibson P. G.","year":"2015","journal-title":"BMJ"},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104976","article-title":"Brainstem Processing of Cough Sensory Inputs in Chronic Cough Hypersensitivity","volume":"100","author":"Moe A. A. K.","year":"2024","journal-title":"eBioMedicine"},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135719","article-title":"TRP Channels in Airway Sensory Nerves","volume":"748","author":"Gu Q.","year":"2021","journal-title":"Neuroscience Letters"},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.15-1271","article-title":"Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial","volume":"149","author":"Vertigan A. E.","year":"2016","journal-title":"Chest"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/thx.2006.064337","article-title":"Efficacy of Speech Pathology Management for Chronic Cough: A Randomised Placebo Controlled Trial of Treatment Efficacy","volume":"61","author":"Vertigan A. E.","year":"2006","journal-title":"Thorax"},{"key":"e_1_2_10_11_1","doi-asserted-by":"crossref","DOI":"10.1177\/19160216251333354","article-title":"Predictive Factors and Treatment Effects of Neuromodulators in Chronic Refractory Cough","volume":"54","author":"Sandham K.","year":"2025","journal-title":"Journal of Otolaryngology \u2010 Head & Neck Surgery"},{"key":"e_1_2_10_12_1","first-page":"1300","article-title":"Botulinum Toxin (BOTOX) for the Treatment of Spastic dysphonia as Part of a Trial of Toxin Injections for the Treatment of Other Cranial Dystonias","volume":"96","author":"Blitzer A.","year":"1986","journal-title":"Laryngoscope"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00005537-199707000-00022","article-title":"Treatment of Ventricular Dysphonia With Botulinum Toxin","volume":"107","author":"Kendall K. A.","year":"1997","journal-title":"Laryngoscope"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/lary.25515","article-title":"Botulinum Toxin Treatment of False Vocal Folds in Adductor Spasmodic Dysphonia: Functional Outcomes","volume":"126","author":"Simpson C. B.","year":"2016","journal-title":"Laryngoscope"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/coa.12333","article-title":"False Vocal Cord Botulinum Toxin Injection for Refractory Muscle Tension Dysphonia: Our Experience With Seven Patients","volume":"40","author":"Pacheco P. C.","year":"2015","journal-title":"Clinical Otolaryngology"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11080459","article-title":"Mechanisms of Botulinum Toxin Type A Action on Pain","volume":"11","author":"Matak I.","year":"2019","journal-title":"Toxins"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","DOI":"10.1177\/03331024221141683","article-title":"OnabotulinumtoxinA Effects on Trigeminal Nociceptors","volume":"43","author":"Moore A. A.","year":"2023","journal-title":"Cephalalgia"},{"key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 Expression in the Trigeminal System by Botulinum Neurotoxin Type\u2010A","volume":"48","author":"Shimizu T.","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/ajo-21-1","article-title":"Laryngeal Botox Injection in Recalcitrant Cases of Chronic Cough","volume":"4","author":"Cook L.","year":"2021","journal-title":"Australian Journal of Otolaryngology"},{"key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/lary.31072","article-title":"Efficacy of Botulinum A Injection to the Laryngeal Adductor Compartment for Treatment of Cough","volume":"134","author":"Campbell B. A.","year":"2024","journal-title":"Laryngoscope"},{"issue":"23","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10235486","article-title":"Supraglottic Botulinum Toxin Improves Symptoms in Patients With Laryngeal Sensory Dysfunction Manifesting as Abnormal Throat Sensation and\/or Chronic Refractory Cough","volume":"10","author":"Novakovic D.","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/resp.12103","article-title":"Laryngeal Sensory Dysfunction in Laryngeal Hypersensitivity Syndrome","volume":"18","author":"Vertigan A. E.","year":"2013","journal-title":"Respirology"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archotol.1966.00760030656012","article-title":"Local Anesthesia for Peroral Endoscopy. Using Superior Laryngeal Nerve Block With Topical Application","volume":"84","author":"Gaskill J. R.","year":"1966","journal-title":"Archives of Otolaryngology \u2010 Head and Neck Surgery"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.1002\/lary.27248","article-title":"Human Laryngeal Sensory Receptor Mapping Illuminates the Mechanisms of Laryngeal Adductor Reflex Control","volume":"128","author":"Sinclair C. F.","year":"2018","journal-title":"Laryngoscope"},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.chest.2024.03.026","article-title":"Laryngeal Dysfunction Manifesting as Chronic Refractory Cough and Dyspnea: Laryngeal Physiology in Respiratory Health and Disease","volume":"166","author":"Sundar K. M.","year":"2024","journal-title":"Chest"},{"key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1044\/2020_JSLHR-20-00350","article-title":"Sensory Innervation of the Larynx and the Search for Mucosal Mechanoreceptors","volume":"64","author":"Foote A. G.","year":"2021","journal-title":"Journal of Speech, Language, and Hearing Research"},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-med-050224-124414","article-title":"Chronic Cough Hypersensitivity as a Neuropathic Disorder: Implications for Management and New Treatments","volume":"77","author":"Chung K. F.","year":"2026","journal-title":"Annual Review of Medicine"},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-9974-10-1","article-title":"Development and Validation of the Newcastle Laryngeal Hypersensitivity Questionnaire","volume":"10","author":"Vertigan A. E.","year":"2014","journal-title":"Cough"},{"key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/lary.23916","article-title":"Development and Validation of the Cough Severity Index: A Severity Index for Chronic Cough Related to the Upper Airway","volume":"123","author":"Shembel A. C.","year":"2013","journal-title":"Laryngoscope"},{"key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0892-1997(02)00097-8","article-title":"Validity and Reliability of the Reflux Symptom Index (RSI)","volume":"16","author":"Belafsky P. C.","year":"2002","journal-title":"Journal of Voice"},{"key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00005537-200409000-00009","article-title":"Development and Validation of the Voice Handicap Index\u201010","volume":"114","author":"Rosen C. A.","year":"2004","journal-title":"Laryngoscope"},{"key":"e_1_2_10_32_1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jval.2015.01.001","article-title":"Responder Definition of a Patient\u2010Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance","volume":"18","author":"Lien H.\u2010C.","year":"2015","journal-title":"Value in Health"},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-024-00769-0","article-title":"Is Laryngeal Hypersensitivity Phenotype the Commonest Presentation Amongst Patients With Refractory Chronic Cough?","volume":"203","author":"Taylor A.","year":"2024","journal-title":"Lung"},{"key":"e_1_2_10_34_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2020.09.008","article-title":"Management of Chronic Refractory Cough in Adults","volume":"81","author":"Visca D.","year":"2020","journal-title":"European Journal of Internal Medicine"},{"key":"e_1_2_10_35_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-1331.2006.01443.x","article-title":"Botulinum Toxin Therapy of Laryngeal Muscle Hyperactivity Syndromes: Comparing Different Botulinum Toxin Preparations","volume":"13","author":"Truong D. D.","year":"2006","journal-title":"European Journal of Neurology"},{"key":"e_1_2_10_36_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1155\/2014\/410415","article-title":"Blockade of Glutamate Release by Botulinum Neurotoxin Type A in Humans: A Dermal Microdialysis Study","volume":"19","author":"Bittencourt da Silva L.","year":"2014","journal-title":"Pain Research and Management"},{"key":"e_1_2_10_37_1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/lary.31075","article-title":"The Application of Superior Laryngeal Nerve Block for Non\u2010Cough Laryngeal Hypersensitivity","volume":"134","author":"Benninger M. S.","year":"2024","journal-title":"Laryngoscope"},{"key":"e_1_2_10_38_1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/lary.27201","article-title":"Treatment of Chronic Neurogenic Cough With In\u2010Office Superior Laryngeal Nerve Block","volume":"128","author":"Simpson C. B.","year":"2018","journal-title":"Laryngoscope"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.70841","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lary.70841","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.70841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:45:54Z","timestamp":1789789554000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.70841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":37,"alternative-id":["10.1002\/lary.70841"],"URL":"https:\/\/doi.org\/10.1002\/lary.70841","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2026-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"lary.70841"}}